Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 24-week results from a randomized controlled trial
… , with similar levels of hypoglycemia compared with placebo (… observed in patients with type 2 diabetes. There were few … symptomatic hypoglycemia (featuring typical hypoglycemia …..... Read More